These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 9491833)

  • 1. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
    Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of medroxyprogesterone acetate on the effects of transdermal oestradiol replacement therapy on plasma lipids.
    Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
    J Obstet Gynaecol; 1998 Mar; 18(2):141-5. PubMed ID: 15512033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Tocopherol and beta-carotene serum levels in post-menopausal women treated with transdermal estradiol and oral medroxyprogesterone acetate.
    Clemente C; Caruso MG; Berloco P; Buonsante A; Giannandrea B; Di Leo A
    Horm Metab Res; 1996 Oct; 28(10):558-61. PubMed ID: 8934216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins. Br J Clin Pharmacol 1998 Feb; 45 (2): 170-172.
    Kneer-Aronoff C
    J Womens Health; 1998 Oct; 7(8):1054-5. PubMed ID: 10026007
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
    Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH
    Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
    J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
    Hänggi W; Birkhäuser MH; Malek A; Peheim E; von Hospenthal JU
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia.
    Sanada M; Tsuda M; Kodama I; Sakashita T; Nakagawa H; Ohama K
    Menopause; 2004; 11(3):331-6. PubMed ID: 15167313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins.
    Os I; Hofstad AE; Brekke M; Abdelnoor M; Nesheim BI; Jacobsen AF; Birkeland K; Larsen A; Midtbo K; Westheim A
    J Intern Med; 2000 Apr; 247(4):433-41. PubMed ID: 10792556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M; Karakoç B; Gürler A
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
    Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
    BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
    Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
    Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.